SGS has successfully implemented advanced techniques for the collection and use of peripheral blood mononuclear cells (PBMCs) for early phase clinical trials at its Clinical Pharmacology Unit (CPU) in Antwerp, Belgium, and is also further strengthening its offer in the areas of infectious disease therapeutics and vaccines. PBMCs are already widely used to study various aspects of pathology and biology in vitro, but are now also more and more used in clinical studies in immunology (including a...